Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-10-15 Abstract: Exciting progress is being made in the early and accurate detection of Alzheimer’s disease (AD) using blood tests. The most promising … Continue reading Alzheimer’s disease Diagnosis and Plasma phospho-tau217-the ADAPT study
Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-09-12 Abstract: Precision metabolomics and quantification for cost-effective rapid diagnosis of disease are the key goals in personalized medicine and point-of-care testing. At … Continue reading Multicorder – Enabling the Future of POC Diagnostics and Screening
Although the need for better diagnostics, especially point-of-care testing, is clear, the uptake of novel technology lags a long way behind demonstration and research papers. Using several case studies from my own research, alongside insight from current state-of-the art notably in diagnostics for microbiology and infection, I will outline the technological basis for bioassay miniaturisation (i.e. tiny blood tests) and discuss the diagnostics innovation pathway. Examples will include a review of >10 years developing microfluidic quantitative multiplex immunoassays that can measure multiple biomarkers in blood, as well as our latest developments in measuring platelet cell function directly in blood.
